Searchable abstracts of presentations at key conferences in endocrinology

ea0007p253 | Clinical case reports | BES2004

Myocardial infarction due to coronary artery spasm in a patient with thyrotoxicosis

Srinivasan R , Sturrock N , Morris K , Patel K

BACKGROUNDAngina and Myocardial infarction have been reported in hyperthyroidism. Intense coronary artery spasm can be life threatening as it can lead to ventricular fibrillation and haemodynamic instability as reported in this patient.CASE HISTORYA 45-year-old lady was admitted with a history of head aches, palpitations, diarrhoea and weight loss. She was subsequently found to have thyrotoxicosis with the th...

ea0011p677 | Reproduction | ECE2006

Impaired vascular function in hypogonadal males is unaltered during monthly treatment cycle with intramuscular testosterone esters

Lane HA , Smith jC , Morris K , Cockcroft J , Goodfellow J , Scanlon MF , Davies JS

Backround: Male hypogonadism is associated with an increased incidence of cardiovascular risk factors and approximately 25% of males suffering with coronary heart disease are hypogonadal. Few studies have assessed the impact of testosterone therapy on vascular function in hypogonadal individuals and none have investigated the weekly impact of gradually reducing testosterone concentrations on vasculature.Patients and Methods: 10 hypogonadal subjects (6 wi...

ea0009p75 | Growth and development | BES2005

A comparison of vascular reactivity in postmenopausal women receiving testosterone and conventional HRT versus conventional HRT

Lane H , Smith J , Davies N , Cockcroft J , Morris K , Scanlon M , Davies J

Backround: Recent research has heightened the controversy surrounding the effects of conventional hormone replacement therapy on cardiovascular risk, suggesting that use of HRT is associated with an increase in cardiovascular morbidity and mortality. Testosterone has also been associated with unfavourable cardiovascular parameters and the addition of testosterone to HRT may augment the risk of cardiovascular events in postmenopausal women.Aim: To elucida...

ea0005p235 | Steroids | BES2003

Cardiovascular risk assessment in bodybuilders abusing anabolic steroids

Lane H , Grace F , Lewis J , Morris K , Thomas A , Scanlon M , Davies J , Cockroft J

Backround: Androgenic anabolic steroids (AAS) are reported to increase cardiovascular risk by causing adverse changes in lipid profiles, impaired glucose tolerance, hyperhomocystinaemia and hypertension. Recent studies have also suggested impaired vascular reactivity in this group.Aim: To assess cardiovascular risk factors and arterial stiffness in AAS using and non-steroid using male bodybuilders and to compare them with healthy controls.Methods: Studies were conducte...

ea0005p246 | Steroids | BES2003

Testosterone reduces free radical release from human monocytes

Lane H , Smith J , Rathbone N , Morris K , Thomas A , Scanlon M , Davies J

Background: Although androgens are traditionally considered to be pro-atherogenic, there is increasing evidence to suggest an inverse relationship between testosterone and cardiovascular risk. Endothelial dysfunction is an early event in the process of atherogenesis and may occur as a result of vascular oxidative damage. In vivo, human monocytes release reactive oxygen intermediates as part of a normal immune response.Aim: This study assessed the contribution of testostero...